Should we routinely use mupirocin to prevent staphylococcal infections? - Wikidata - thesis-toulmin - TriplyDB

Should we routinely use mupirocin to prevent staphylococcal infections?

Should we routinely use mupirocin to prevent staphylococcal infections?

http://www.wikidata.org/entity/Q44771600

about

A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions.

P2860

Q40937956-8817A38D-122B-47F1-B9CF-AAC8578A8CFB

P2860

Should we routinely use mupirocin to prevent staphylococcal infections?

http://www.wikidata.org/entity/Q44771600

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh-hant

name

Should we routinely use mupirocin to prevent staphylococcal infections?

@en

Should we routinely use mupirocin to prevent staphylococcal infections?

@nl

type

label

Should we routinely use mupirocin to prevent staphylococcal infections?

@en

Should we routinely use mupirocin to prevent staphylococcal infections?

@nl

prefLabel

Should we routinely use mupirocin to prevent staphylococcal infections?

@en

Should we routinely use mupirocin to prevent staphylococcal infections?

@nl

P1433

Q44771600-879F4AE5-4B9D-4661-BF01-B217C821C812

P1476

Q44771600-8EF5665E-6376-4F69-B855-C6B1BE880B85

P2093

Q44771600-03B9BE72-65BD-4A37-B78E-36EBF63D60ED

Q44771600-0E961282-92C3-4997-94B9-137735A7C0EC

Q44771600-443D93BB-30F2-4E89-97B5-725B9DB16158

Q44771600-475D8BC7-F365-4651-B105-56D38DD69B58

Q44771600-C601B131-B209-44D6-85F1-50A612EC28B3

Q44771600-E1D3DFC6-100C-4C0C-B46B-46F40A055059

Q44771600-F4258666-815D-4A5A-8D16-EA06C67D9453

P2860

Q44771600-15AC7448-4C92-4DB7-862B-3CA019062368

Q44771600-1C364541-75D6-4D4C-896A-26BE3D9E5DDE

Q44771600-5EBAD67E-B004-48F2-97AC-A635953852F2

Q44771600-66154B1A-8E1E-49E4-B81C-5921F33EFDB2

Q44771600-93488DF7-589C-4F5F-BA45-4D44CB905FAD

Q44771600-AA0A621A-CE42-4CCA-A072-AB5301C49883

Q44771600-C6F28DB8-B88F-4817-BB86-91A59A5FE99B

Q44771600-E03095B6-8EB4-4911-A123-515A7E45C1C2

Q44771600-E8077ED7-EDFB-4F21-A040-7F3D5999E985

P304

Q44771600-C3395DC5-1850-4C8B-B99A-7A38B7495486

P31

Q44771600-0D1657D5-09FC-42B0-B9E8-E0B7A426EAB0

P356

Q44771600-A9EBE24A-84C2-4CE3-B71A-96AD17A51F6A

P433

Q44771600-5B9F41E6-64FA-42D3-9E6F-FA10F56DBFB8

P478

Q44771600-89EB65BE-0527-4F11-AFB0-5F7220EC9FF0

P577

Q44771600-DC4FC1BC-F87E-433B-B3DF-14484ADE0045

P698

Q44771600-1C15030F-02AE-43AA-9825-22D3B420F624

P356

P1433

Infection Control and Hospital Epidemiology

P1476

Should we routinely use mupirocin to prevent staphylococcal infections?

@en

P2093

A DeMaria

http://www.w3.org/2001/XMLSchema#string

A H Sohn

http://www.w3.org/2001/XMLSchema#string

C Murphy

http://www.w3.org/2001/XMLSchema#string

R L Sinkowitz-Cochran

http://www.w3.org/2001/XMLSchema#string

T M Perl

http://www.w3.org/2001/XMLSchema#string

V R Roth

http://www.w3.org/2001/XMLSchema#string

W R Jarvis

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial resistance in intensive care units.

Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

The economic impact of Staphylococcus aureus infection in New York City hospitals.

The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection.

New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage.

Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.

Program overview: the reality check sessions at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections.

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

P304

745-749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/501720

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11089665

http://www.w3.org/2001/XMLSchema#string